Page last updated: 2024-10-26

disopyramide and Besnier-Boeck Disease

disopyramide has been researched along with Besnier-Boeck Disease in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Research Excerpts

ExcerptRelevanceReference
" Sustained rapid ventricular tachyarrhythmias requiring cardioversion for termination were induced by double right ventricular apical extrastimuli during control, and treatment with disopyramide, quinidine, and fluocortolone."3.67Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. ( Belhassen, B; Laniado, S; Pines, A, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belhassen, B1
Pines, A1
Laniado, S1

Other Studies

1 other study available for disopyramide and Besnier-Boeck Disease

ArticleYear
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
    Chest, 1989, Volume: 95, Issue:4

    Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combina

1989